Get started
Author

Karan Vadher

Observed names: K. Vadher, Karan D Vadher, Vadher, Karan
ORCID: 0000-0002-6287-5596
Observed ORCID: 0000-0002-6287-5596
OpenAlex ID: A5023314227
Problems persist in reporting of methods and results for the WOMAC measure in hip and knee osteoarthritis trials
2018 · B. Copsey, J. Y. Thompson, et al. · Quality of Life Research · 76
PDF
Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison
2022 · Karan Vadher, Hiren Patel, et al. · Diabetes Obesity and Metabolism · 55
Sample size calculations are poorly conducted and reported in many randomized trials of hip and knee osteoarthritis: results of a systematic review
2018 · Bethan Copsey, Jacqueline Y. Thompson, et al. · Journal of Clinical Epidemiology · 32
PDF
Better Outcomes for Older people with Spinal Trouble (BOOST) Trial: a randomised controlled trial of a combined physical and psychological intervention for older adults with neurogenic claudication, a protocol
2018 · Esther Williamson, Lesley Ward, et al. · BMJ Open · 25
PDF
Negative-pressure wound therapy compared with standard dressings following surgical treatment of major trauma to the lower limb: the WHiST RCT
2020 · Matthew L Costa, Juul Achten, et al. · Health Technology Assessment · 20
PDF
Design, analysis and reporting of multi-arm trials and strategies to address multiple testing
2020 · Ayodele Odutayo, Dmitry Gryaznov, et al. · International Journal of Epidemiology · 16
PDF
Predicting patient-reported and objectively measured functional outcome 6 months after ankle fracture in people aged 60 years or over in the UK: prognostic model development and internal validation
2019 · David J Keene, Karan Vadher, et al. · BMJ Open · 13
PDF
Standard wound management versus negative-pressure wound therapy in the treatment of adult patients having surgical incisions for major trauma to the lower limb—a two-arm parallel group superiority randomised controlled trial: protocol for Wound Healing in Surgery for Trauma (WHIST)
2018 · Juul Achten, Karan Vadher, et al. · BMJ Open · 13
PDF
Is the timed loaded standing test a valid measure of back muscle endurance in people with vertebral osteoporosis?
2018 · M. Newman, R. Newman, et al. · Osteoporosis International · 12
COmmunity-based Rehabilitation after Knee Arthroplasty (CORKA): statistical analysis plan for a randomised controlled trial
2018 · Karan Vadher, Ruth Knight, et al. · Trials · 8
PDF
RIVA – a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial
2018 · Sean H. Lim, Kim M. Linton, et al. · Trials · 8
PDF
Development and validation of a prediction model for self-reported mobility decline in community-dwelling older adults
2022 · Maria T. Sanchez-Santos, Esther Williamson, et al. · Journal of Clinical Epidemiology · 7
PDF
Current practice in methodology and reporting of the sample size calculation in randomised trials of hip and knee osteoarthritis: a systematic review
2018 · B. Copsey, J.Y. Thompson, et al. · Osteoarthritis and Cartilage · 3
PDF
Development and Internal Validation of a Prognostic Model to Predict Functional Outcomes 6 Months After Ankle Fracture in Older Adults
2026 · David J. Keene, Karan Vadher, et al. · World Physiotherapy Congress Archive
An Emg Investigation of Erector Spinae Muscle Activity During the Timed Loaded Standing Test in People With Vertebral Osteoporosis
2026 · Karen Barker, Meredith Newman, et al. · World Physiotherapy Congress Archive
Author response for "Efficacy of tirzepatide 5, 10, and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: an adjusted indirect treatment comparison"
2022 · Karan Vadher, Hiren Patel, et al.
Author response for "Efficacy of tirzepatide 5, 10, and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: an adjusted indirect treatment comparison"
2022 · Karan Vadher, Hiren Patel, et al.
PDB39 Dosing Patterns Among Patients with Type 2 Diabetes (T2D) Initiating Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) in France and the Netherlands
2021 · K. Norrbacka, V. Divino, et al. · Value in Health
CONFIRM: A phase III randomized trial to evaluate the efficacy of nivolumab versus placebo in relapsed mesothelioma.
2018 · Dean Anthony Fennell, Emma Victoria Kirkpatrick, et al. · Journal of Clinical Oncology
Works count: 20
Citation count: 288
H-index: 9
I10-index: 9
Year
Topic
Type